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Abstract
BACKGROUND: To assess the probability of perfusion defects
at exercise stress myocardial perfusion SPECT scintigraphy from
pretest clinical diagnosis (medical personal history, previous
ergometric investigation). To determine the value of clinical fac-
tors for probability of scintigraphic defects with respect to avoid-
ing unnecessary investigation in subjects with low probability
of abnormal scintigrams.
MATERIAL AND METHODS: 2143 subjects (1235 men, 908
women) were investigated by SPECT perfusion scintigraphy at
stepwise increasing exercise stress. They were divided into three
groups with regard to their medical history and exercise test at
scintigraphy: subjects without any signs of coronary artery dis-
ease (CAD), patients with high likelihood of CAD (i.e., typical
anginal pain, in particular at stress, positive stress ECG chang-
es, angiographically documented important CAD) and patients
after myocardial infarction (MI). Important risk factors (hyper-
tension, diabetes, age and sex), as well as the role of revascu-
larisation procedures, were taken into account for multiple lo-
gistic regression in order to express their importance for the
odds of scintigraphic defect visualisation.
RESULTS: Perfusion scintigraphic defects (PSD) were found in
5.2% of subjects without signs of CAD, in contrast to patients
with manifest CAD (68.8% with PSD) and in those after MI (90.2%
with PSD). There were other important factors corroborating
the likelihood of PSD (in decreasing order of importance): dia-
betes, male, ECG changes at stress, increasing age. Success-
ful revascularisation improved scintigraphic images.
CONCLUSION: The examination of CAD symptom-free subjects,
in particular with atypical chest discomfort, is useless. SMPS in
patients after documented MI is to be carried out for other in-
tended purposes, not for CAD diagnosis only. SMPS is highly
recommended in patients with CAD symptoms and high CAD
probability in order to decide further treatment and prognosis.
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Introduction
SPECT stress myocardial perfusion scintigraphy (SMPS) has
been widely used as an important non-invasive procedure for diag-
nosis of coronary artery disease (CAD). However, the price of SMPS
is not negligible; it is represented by the sum of the radiopharmaceu-
tical price, the salary of staff members and the machine time of the
SPECT gamma camera. The price of myocardial perfusion imaging
alone was estimated in four great European countries to be approx-
imately £220 [1]. Based on the cost-effectiveness relation, SMPS
must be carefully indicated in order to obtain important data that are
essential for patients treatment and prognosis. No doubt selection
of patients for SMPS could be made very effectively by an experi-
enced clinician from medical history and previous exercise testing.
The aim of this article was to check the value of pretest clinical
data (patients medical history, result of exercise test) for an esti-
mation of the occurrence rate of perfusion scintigraphic defects
(PSD) in SMPS. The main reason for our study was to improve the
indication for SMPS in order to avoid unnecessary investigations
in subjects with low probability of PSD and to economise this type
of non-invasive diagnostic method for patients with high probabil-
ity of important CAD.
Material and methods
Patients. 2143 patients (1235 men, 908 women), mean age
59.2 – 19.1 (STD) years, considered by a clinician to have CAD,
were investigated by SMPS.
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Medical history. The course of the disease was described
by a clinician with special regard to the attacks of anginal pain
(AP), previous myocardial infarction (MI), revascularisation pro-
cedures, performed exercise stress test, hypertension and diabe-
tes. The patients were classified according to their medical histo-
ry into three groups: CAD unlikely (subjects free of any typical
symptom), CAD clinically manifest (typical symptoms of AP of dif-
ferent intensity, documented CAD by angiography) and CAD with
previous MI.
Exercise at SMPS. All patients exercised on bicycle ergom-
eter (Ergo-line 900, The Netherlands) in semi-supine position. They
started at 50 W and the load was step-wise increased every minute
for 25 W. Heart frequency, blood pressure and precordial ECG
were automatically registered. In accordance with common us-
age, the radiopharmaceutical was injected either one minute prior
to the end of maximal reached load, or immediately at the end of
exercise, stopped either for increasing chest pain or other circum-
stances [2].
SMPS exercise evaluation. The occurrence of anginal pain
was monitored within the stress exercise and a horizontal or de-
creasing ST depression in precordial ECG records greater than
0.1 mV was taken into account.
Injected radiopharmaceuticals. Predominantly (in 1235 pa-
tients. i.e. 64.4%) 550 MBq of 99mTc-SestaMIBI (Cardiolite, Dupont,
USA or Cardiospect, FJC Institute, Hungary) were injected; in the
minority of patients we used either 550 MBq of 99mTc-tetrofosmin
(Myoview, Amersham, UK, in 391 patients, i.e. 18.3%) or 74 MBq of
201Tl-thalium chloride (Mallinckrodt, Germany, 372 patients, 17.3%).
The choice of used radiopharmaceutical was made at random.
SPECT scintigraphy. Scintigraphy was carried out on dual-
head gamma camera DST-XL (SMV, France) and scintigrams were
processed by Vision POWER-station 4.0 programs. The criteria
for PSD presence were the same for the whole study, irrespective
of the radiopharmaceuticals used, i.e. an accumulation defect
evident in three-dimensional images, circumferential profiles as
well as in polar maps; only defects evaluated by the processing
program as statistically significant were taken into account.
Statistical evaluation. Data were examined by multiple logistic
regression with stepwise algorithm, when the presence or absence
of PSD (dependent variable) was tested against sex, age, clinical
diagnosis (CAD unlikely, CAD clinically manifest or MI in medical his-
tory), positive ECG changes at SMPS exercise, diabetes and hyper-
tension (independent variables). Their significance was evaluated by
means of F-test and their probability according to c2 test.
Results
The mean maximal load (– STD) at SMPS exercise was 136.7
W – 29.1. At least 3/4 of prescribed aerobic capacity (according
to sex and age) was reached at this load in the great majority of
examined subjects. However exercise testing was stopped early
due to AP in 249 patients; a small number of patients were unable
to increase substantially the load for lower extremity weakness.
1114 persons were without any definite signs of CAD (no or
non-anginal chest pain and negative stress test even in medical
history). 562 patients revealed clinically manifest CAD symptoms
(typical AP, positive stress test, or documented CAD by former
angiography) and 467 patients were after MI.
1056 subjects of the first group without CAD signs (94.8%)
had normal scintigraphic finding, whereas PSD was observed in
58 only (5.2%, PSD predominantly of a small size, without any sex
prevalence). The incidence of PSD in the group of patients with
clinically manifest CAD was found in 387 patients (68.8%) and
PSD was absent in 175 patients (31.2%). The clinical diagnosis of
MI was predominantly connected with pathologic SMPS scinti-
grams; marked PSD were in 424/467 patients with history of MI
(90.8%) and only 43 patients (9.2%) had SMPS free of PSD.
Special attention was paid to the non-anginal chest pain in
subjects without definite evidence of CAD. This symptom, in fact
predominantly neurocirculatory asthenia and often of spondylar-
throtic origin, was the reason for SMPS investigation in 300 fe-
male and 154 male subjects. However PSD were found in 5.7%
(17/300) of women and in 25.3% (39/154) of men with this disor-
der. Non-anginal chest pain, sometimes called atypical chest pain,
is a therefore moderately weak predictor of positive SMPS results
in men without other evidence of CAD, and a very weak one in
women.
79 patients without previous MI history had a horizontal or
decreasing ST segment depression more than 0.1 mV in ECG at
SMPS stress exercise. This finding alone had a certain significance
for PSD existence but the magnitude of depression did not play
any important role in predicting the occurrence of PSD (Fig. 1).
On the basis of multiple logistic regression some factors from
medical history and exercise stress at SMPS were estimated to
be significant for PSD prediction. Our system of statistical evalua-
tion enabled the construction of a point scale and a list of pretest
factors important for PSD presence, with an assigned number of
points according to their significance (Table 1). The data of per-
sonal history revealed the highest likelihood for finding PSD, clas-
sifying the patients with great probability in those with or without
clinical diagnosis of CAD. Further on, the probability of PSD was
significantly influenced by diabetes and sex (men), less by stress
Figure 1. The distribution of horizontal or descending ST segment de-
pression greater than 0.1 mV in precordial ECG leads observed in 79
subjects without previous MI history (43 men, 36 women) at SMPS exer-
cise. There was neither prevalence of ST changes in 37 patients with PSD
(23 men, 14 women), as compared with 42 without PSD (20 men, 22
women), nor any correlation between the magnitude of ST depression
and PSD.
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ECG changes and age, but not by hypertension. Previous revas-
cularisation in verified CAD improved the scintigraphic image. The
points of significant factors and the sum of their combination re-
sulted in a score that was used for the construction of a diagram
determining the probability of scintigrams with PSD, strongly cor-
roborating the diagnosis of important CAD (Fig. 2).
Discussion
SMPS is one of the few fundamental non-invasive methods
recommended for probability assessment of clinical diagnosis of
CAD [3]. It was demonstrated in asymptomatic aircrew members
that normal SMPS ruled out the presence of significant CAD [4].
The indication for SMPS seems to be abundantly used, predomi-
nantly by general practitioners, but by cardiologists too [5]. The
selection for SMPS is usually made on the basis of careful medi-
cal history and stress test; however there are important differenc-
es in the relevance of these pretest data.
According to our results the strongest indicator for the ap-
pearance of PSD is the unambiguous evidence of healed trans-
mural MI; a normal scintigram speaks in fact in favour of false
positive clinical diagnosis of transmural MI in the past. SMPS has
a value in these patients only for other specified reasons (the pres-
ence and worsening of AP, suspicion of a new lesion of another
coronary artery, myocardial viability before intended revasculari-
sation). Further on, our results are in agreement with the likeli-
hood of significant CAD using additional variables, such as sex,
age, diabetes and typical AP [6]. The ST depression was seldom
connected with PSD in the minority of patients without previous
MI; also we did not see any relationship between the incidence of
PSD and the range of ST depression, either in males or females. It
is known that the prediction of ST depression alone is low for the
diagnosis of significant CAD [7, 8] and we can add that ST seg-
ment depression at stress test is not a strong predictor for the
presence of PSD at SMPS.
The frequently mentioned information of non-anginal or atyp-
ical chest pain is a common reason for SMPS, in particular in fe-
males. However an abnormal scintigram in those subjects was
very rare. This fact is quite in agreement with the low probability of
significant CAD in population with atypical chest pain [6] that does
not increase CAD risk [9]. The atypical and non-anginal chest pain
alone, in particular in young women, is not any indication for SMPS.
There remains a question whether SMPS could be a suitable
method for silent ischaemia disclosure in asymptomatic popula-
tion. Silent ischaemia is very exceptional in the common popula-
tion and even abnormal scintigrams in symptom-free subjects are
Table 1. Clinical factors significant for PSD finding determined by
multiple logistic regression. Assigned point number expresses the
importance in decreasing order. Note the influence of previous
revascularisation for decreasing odds to find PSD at SMPS
Factors affecting PSD presence Points
Previous MI 55.3
 + revascularisation 43.1
Manifest CAD 37.3
 + revascularisation 29.0
Diabetes 9.7
Males 9.2
ST depression at stress 6.3
Age: >70 y. 2.4
6170 y.  1.6
5160 y.   0.8
Age < 50 y.; females; without diabetes;
normal stress ECG; without CAD symptoms 0.0
Figure 2. A diagram of PSD probability constructed by means of logistic regression. The diagram en-
ables us to evaluate the probability of PSD finding by the sum of points of pretest clinical factors men-
tioned in Table 1.
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often false-positive [10]. Therefore we feel that the indication for
SMPS as a screening method in asymptomatic and CAD risk fac-
tor free population is not justified.
The patients undergoing SMPS investigation could be principal-
ly divided into three groups with respect to the usefulness and ben-
efit of SMPS. Subjects without risk factors, in particular young and
premenopausal women with non-anginal chest discomfort and with-
out serious diabetes, represent the first group with very low probabil-
ity of CAD; SMPS in these subjects is therefore useless. On the other
hand patients with sure evidence of serious CAD (above all after
transmural MI) do not need the certification of CAD existence only
and they might be investigated for some other above-mentioned
special purposes. There remains a third group of patients with a pre-
test 25%-85% probability (Fig. 2) of positive PSD finding suffering
from typical AP, frequently connected with other risk factors (in partic-
ular diabetes). SMPS is fully indicated in these patients as an impor-
tant non-invasive test for confirmation of CAD (its extent, possible
myocardial viability and prognosis) and for decision of further thera-
py. These patients might also be repeatedly investigated by SMPS
after successful revascularisation in order to evaluate objectively the
potential improvement after the revascularisation procedure. We pre-
sume that this group of patients has the greatest benefit from SMPS
and they have to be preferentially investigated.
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